Brainstorm Cell Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCLI and other ETFs, options, and stocks.

About BCLI

Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function.

CEO

Chaim Lebovits

CEOChaim Lebovits

Employees

Employees29

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2000

Founded2000

Employees

Employees29

BCLI Key Statistics

Market cap

34.91M

Market cap34.91M

Price-Earnings ratio

-1.32

Price-Earnings ratio-1.32

Dividend yield

—

Dividend yield—

Average volume

1.34M

Average volume1.34M

High today

$0.59

High today$0.59

Low today

$0.4512

Low today$0.4512

Open price

$0.5634

Open price$0.5634

Volume

1.08M

Volume1.08M

52 Week high

$3.37

52 Week high$3.37

52 Week low

$0.134

52 Week low$0.134

BCLI News

TipRanks 2d

Brainstorm Cell Therapeutics Executive Leadership Changes - TipRanks.com - TipRanks

Brainstorm Cell Therapeutics (BCLI) has provided an update. Brainstorm Cell Therapeutics Inc. announced on April 16, 2024, the resignation of Dr. Stacy Lindbor...

Yahoo Finance 2d

BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of ... - Yahoo Finance

Bob Dagher, MD, Promoted to Chief Medical Officer Dr. Stacy Lindborg Stepping Down as Co-CEO and Transitioning to Board of Directors NEW YORK, April 16, 2024...